Posts by: Alice Melão

News

A rise in the volume of red blood cells may help to identify people with chronic obstructive pulmonary disease who are at risk of also developing pulmonary hypertension, a ... Read more

August 2, 2019August 2, 2019

Analyzing Exhaled Breath in Differing Positions May Be ‘Simple and Safe’ Way of Monitoring CTEPH

CTEPH News, News, PH News

Analysis of gas exhaled in differing positions, like sitting or laying flat, could be a noninvasive and simple alternative to right heart catheterization in evaluating and managing people with chronic ... Read more

July 31, 2019August 5, 2019

Better Risk Assessment Needed to Improve Care in PAH, International Survey Shows

News, PAH News

While physicians worldwide are conducting multi-parametric risk assessments to evaluate pulmonary arterial hypertension (PAH), they are not doing so to the extent recommended by current guidelines, results from an ... Read more

July 18, 2019July 18, 2019

Long-term Orenitram Use Can Help PAH Patients Walk Longer Distances, Extension Trial Finds

News, PAH News

Long-term use of Orenitram led to moderate but durable, and dose dependent, improvements in exercise capacity in pulmonary arterial hypertension (PAH) patients, results from an open-label extension trial show. These findings ... Read more

July 11, 2019July 11, 2019

Implantable CardioMEMS System Useful in Predicting Heart Failure Risk in PAH, Study Shows

News, PAH News

Abbott’s CardioMEMS HF system — a wireless heart failure monitor — can be safely used to monitor blood flow (hemodynamics) changes and help predict the risk of heart failure ... Read more

June 21, 2019June 27, 2019

FDA Approves Generic Bosentan Tablets in US for PAH Treatment

News, PAH News

A new generic version of Actelion’s Tracleer (bosentan) developed by Teva Pharmaceutical was approved by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension ... Read more

June 7, 2019June 7, 2019

Liquidia Moves Closer to Requesting FDA Approval of LIQ861 for PAH

News, PAH News

The latest INSPIRE Phase 3 trial data on LIQ861 as a treatment for pulmonary arterial hypertension (PAH) support the submission of a New Drug Application (NDA) with the U.S. ... Read more

April 1, 2019April 1, 2019

Increased Production of Nestin Protein Involved in PAH Development, Study Suggests

News, PAH News

Increased production of a protein called Nestin by cells lining the blood vessels in the lungs may contribute to the development and progression of pulmonary arterial hypertension (PAH), a ... Read more

March 20, 2019March 26, 2019

Opsumit Has Potential to Improve Right Ventricle Function in PAH Patients, Phase 4 Data Show

News, PAH News

Treatment with Opsumit (macitentan) can significantly improve the heart’s right ventricular function, reverse cardiac tissue remodeling, and reduce pulmonary vascular resistance (PVR) in patients with pulmonary arterial hypertension (PAH), preliminary ... Read more

March 18, 2019March 26, 2019

Cell Therapies Show Potential as Treatment for PAH, Review Finds

News, PAH News

Regenerative cell therapy can induce significant improvements in key clinical features of pulmonary arterial hypertension (PAH) in animal models, a review study shows. The study’s findings suggest that such ... Read more

Posts by: Alice Melão

Alice Melão

Red Blood Cell Volume May Be Marker of COPD Patients at Risk of PH, Study Suggests

Analyzing Exhaled Breath in Differing Positions May Be ‘Simple and Safe’ Way of Monitoring CTEPH

Better Risk Assessment Needed to Improve Care in PAH, International Survey Shows

Long-term Orenitram Use Can Help PAH Patients Walk Longer Distances, Extension Trial Finds

Implantable CardioMEMS System Useful in Predicting Heart Failure Risk in PAH, Study Shows

FDA Approves Generic Bosentan Tablets in US for PAH Treatment

Liquidia Moves Closer to Requesting FDA Approval of LIQ861 for PAH

Increased Production of Nestin Protein Involved in PAH Development, Study Suggests

Opsumit Has Potential to Improve Right Ventricle Function in PAH Patients, Phase 4 Data Show

Cell Therapies Show Potential as Treatment for PAH, Review Finds

Pin It on Pinterest